EFPIA - NEWSLETTER

EFPIA Newsletter 20 November 2025

Can the Critical Medicines Act deliver for Europe?

By Nathalie Moll, Director General, EFPIA

If appropriately designed, the CMA offers an opportunity to improve medicines availability and strengthen Europe’s competitiveness.

As trilogue discussions on the Critical Medicines Act (CMA) approach, its potential effects on medicine supply, patient access and Europe’s competitiveness are increasingly in focus.

From an industry standpoint, several considerations are central to understanding how this act can best achieve its objectives and support a robust pharmaceutical ecosystem in Europe.

Blogs

18 November 2025 The Unseen Arsenal: Why health is the new economic battleground (Guest blog)

As geopolitical tensions intensify, a nation’s true strength may lie in its ability to invest in human capital and ensure...

AMR Awareness Week

As we mark AMR Awareness Week, EFPIA was honoured to participate in the Danish EU Presidency High-Level Conference on AMR to discuss how to accelerate the development of new, effective antibiotics.

Antimicrobial resistance is a growing global health threat. Despite strong prevention and stewardship efforts, resistance remains inevitable. Without effective antimicrobials, routine medical treatments and procedures become dangerous again. Yet, today’s pipeline remains alarmingly thin because the market model is broken. These medicines must be used rarely, yet always be available.

How can Europe tackle AMR? Find out more here.

Europe has a choice to make

New treatments for Hep C now cure over 98% of patients, replacing a lifetime of costly care.
In Belgium, that saves €11,000 per patient.

Will Europe invest in innovative treatments like this or pay the cost of care?

Learn more here.

Events

01 DEC 2025

“Europe’s Beating Cancer Plan in Action: National Implementation for the Future”... Online

The EFPIA Oncology Platform and Cancer Patients Europe are delighted to invite you to the launch webinar of their new...

Learn more →

01 DEC 2025

World AIDS Day 2025: Redefining the Journey Online

The event will feature the latest data on HIV/AIDS from ECDC and the WHO Regional Office for Europe.

Learn more →

03 DEC 2025

EMA Information Day on submission predictability of initial marketing authorisation... Online

The focus of this interactive Information Day will be to enhance a common understanding, raise awareness of the challenges...

Learn more →

04 DEC 2025

Future-proofing Alzheimer’s care: scaling innovation for a healthier Europe Online

Explore how new therapies and scalable solutions can transform care pathways and strengthen health systems.

Learn more →

What we are reading

The status quo of the development of decentralized clinical trials 19 November 2025 (Frontiers)

The 25 most powerful ideas of the 21st century (so far), picked by the world’s top thinkers... 15 November 2025 (Science Focus)

How to cure type 1 diabetes: transforming research into policy change 14 November 2025 (IHI)

Animal testing phaseout needs partnership delivery model 13 November 2025 (Euractiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶